---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-23-000608"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2023-04-25T23:59:59+00:00"
generated_at: "2026-06-16T18:00:10.366670+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# USANA Q1 net sales $248M, EPS $0.95; raises FY23 guidance low end

## Summary
- Net sales $248M, +9% sequentially but -9% YoY; diluted EPS $0.95 (+44% sequentially, -17% YoY).
- FY2023 guidance raised: net sales $875-$950M (previously $850-$950M), EPS $2.40-$3.30 (prev $2.35-$3.30).
- Active customers 491,000, flat sequentially, -11% YoY; Asia Pacific net sales $200M (80% of total).
- Q1 included ~$12M China COVID-demand benefit and ~$13M price-increase pull-forward; new market expansion planned.
- Ended quarter with $295M cash, debt-free; no share repurchases; $83M remaining under authorization.

## SEC filing metadata
- accession: 0001157523-23-000608
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2023-04-25T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000115752323000608/0001157523-23-000608-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000115752323000608/a53387511.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-23-000608
- JSON: https://secwatch.observer/filing/0001157523-23-000608.json
- Plain text: https://secwatch.observer/filing/0001157523-23-000608.txt

## Key facts
- Earnings Releases
  USANA HEALTH SCIENCES INC reported the first quarter ended April 1, 2023 results: revenue $248 million, EPS $0.95. Guidance raised.
  - Period: the first quarter ended April 1, 2023
  - Revenue: $248 million
  - EPS: $0.95
  - Guidance: raised
  - Result: reported results
  source text: First quarter net sales were $248 million versus $228 million for the fourth quarter of 2022 and $273 million during the first quarter of 2022. First quarter diluted EPS was $0.95 as compared with $0.66 for the fourth quarter of 2022 and $1.15 during the first quarter of 2022. Generated $13 million of operating cash flow during the quarter. Fiscal 2023 net sales and diluted EPS guidance updated to $875 to $950 million and $2.40 to $3.30, respectively, from $850 million to $950 million and $2.35 to $3.30.
  evidence_url: https://www.sec.gov/Archives/edgar/data/896264/000115752323000608/0001157523-23-000608-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.